Blue light is produced naturally by the sun and generated by computer monitors, smartphone screens and other digital devices. Although the light has some beneficial effects, exposure can increase ...View Article
You are using an outdated browser. Please upgrade your browser to improve your experience.
Blepharitis is long-term inflammation of the eyelids and eyelashes. It can affect people of all ages. Usually, blepharitis causes burning, itching, and irritation of the eyelids. In severe cases, the disease can lead to styes and/or inflammation of the cornea.
Staphylococcal blepharitis is cause by “staph” bacteria. This type of blepharitis is characterized by dense crusts around the patient’s eyelashes, and may cause discomfort when attempting to open one’s eyes in the morning. The patient can experience a loss of eyelashes, stye formation, and even small skin ulcers.
Seborrheic blepharitis shows similar symptoms to “staph” blepharitis, but appears slightly differently during an eye exam. While “staph” crusts are dry, seborrheic crusting is more greasy. These patients may also suffer from seborrheic dermatitis.
Meibomian Gland Dysfunction
Meibomian glands normally produce thin oily secretions, which form an important part of the tear film. When the glands fail to work properly, an abnormally thick secretion may result. This causes local inflammation, and patients can experience redness and burning. An erratic tear film that evaporates quickly may also result, causing chronic dry eye.
It is important to understand that blepharitis is a chronic condition. Even with proper treatment, the symptoms can recur numerous times over months to years. The main treatments for all forms of blepharitis are warm soaks, eyelid scrubs, and oral fish oil or omega-3 pills:
Warm Soak Directions:
Eyelid Scrub Directions:
Cases that do not improve or respond to the above treatment may require additional therapies. Examples are antibiotic ointment or even steroids for patients with moderate to severe “staph” blepharitis, and oral antibiotics such as tetracycline for patients with severe meibomian gland dysfunction.